ReviewJournal of neuromuscular diseases2026

Paediatric medicines development for Duchenne muscular dystrophy: An EU regulatory perspective.

Sylvie Benchetrit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.